These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 10545286)
41. Influence of applied tension and nitric oxide on responses to endothelins in rat pulmonary resistance arteries: effect of chronic hypoxia. MacLean MR; McCulloch KM Br J Pharmacol; 1998 Mar; 123(5):991-9. PubMed ID: 9535030 [TBL] [Abstract][Full Text] [Related]
42. Docosahexaenoic acid inhibits development of hypoxic pulmonary hypertension: in vitro and in vivo studies. Yan J; Chen R; Liu P; Gu Y Int J Cardiol; 2013 Oct; 168(4):4111-6. PubMed ID: 23907044 [TBL] [Abstract][Full Text] [Related]
43. CPU0507, an endothelin receptor antagonist, improves rat hypoxic pulmonary artery hypertension and constriction in vivo and in vitro. Yuan SH; Dai DZ; Guan L; Dai Y; Ji M Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1066-72. PubMed ID: 17042916 [TBL] [Abstract][Full Text] [Related]
50. Hypoxic pulmonary hypertension is prevented in rats with common bile duct ligation. Imamura M; Luo B; Limbird J; Vitello A; Oka M; Ivy DD; McMurtry IF; Garat CV; Fallon MB; Carter EP J Appl Physiol (1985); 2005 Feb; 98(2):739-47. PubMed ID: 15516365 [TBL] [Abstract][Full Text] [Related]
51. Expression of endothelin-1 in rats developing hypobaric hypoxia-induced pulmonary hypertension. Nakanishi K; Tajima F; Nakata Y; Osada H; Tachibana S; Kawai T; Torikata C; Suga T; Takishima K; Aurues T; Ikeda T Lab Invest; 1999 Nov; 79(11):1347-57. PubMed ID: 10576205 [TBL] [Abstract][Full Text] [Related]
52. Hypotensive effect of endothelin-1 via endothelin-B-receptor pathway on pulmonary circulation is enhanced in rats with pulmonary hypertension. Sakai S; Miyauchi T; Hara J; Goto K; Yamaguchi I J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S95-8. PubMed ID: 11078347 [TBL] [Abstract][Full Text] [Related]
53. Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat. Kantores C; McNamara PJ; Teixeira L; Engelberts D; Murthy P; Kavanagh BP; Jankov RP Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L912-22. PubMed ID: 16829630 [TBL] [Abstract][Full Text] [Related]
54. Bosentan attenuates right ventricular hypertrophy and fibrosis in normobaric hypoxia model of pulmonary hypertension. Choudhary G; Troncales F; Martin D; Harrington EO; Klinger JR J Heart Lung Transplant; 2011 Jul; 30(7):827-33. PubMed ID: 21550822 [TBL] [Abstract][Full Text] [Related]
55. Nitrendipine attenuates the pulmonary vascular remodeling and right ventricular hypertrophy caused by intermittent hypoxia in rats. Michael JR; Kennedy TP; Buescher P; Farrukh I; Lodato R; Rock PC; Gottlieb J; Gurtner G; de la Monte SM; Hutchins GM Am Rev Respir Dis; 1986 Mar; 133(3):375-9. PubMed ID: 2937355 [TBL] [Abstract][Full Text] [Related]
56. Genetic disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxic mice. Klinger JR; Warburton RR; Pietras LA; Smithies O; Swift R; Hill NS Am J Physiol; 1999 May; 276(5):L868-74. PubMed ID: 10330043 [TBL] [Abstract][Full Text] [Related]
57. The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo. Holm P; Liska J; Franco-Cereceda A Cardiovasc Res; 1998 Mar; 37(3):765-71. PubMed ID: 9659461 [TBL] [Abstract][Full Text] [Related]
58. A novel and selective endothelin ET(A) receptor antagonist YM598 prevents the development of chronic hypoxia-induced pulmonary hypertension in rats. Yuyama H; Fujimori A; Sanagi M; Koakutsu A; Noguchi Y; Sudoh K; Sasamata M; Miyata K Vascul Pharmacol; 2005 Jun; 43(1):40-6. PubMed ID: 15975532 [TBL] [Abstract][Full Text] [Related]
59. Enhanced alpha1-adrenergic trophic activity in pulmonary artery of hypoxic pulmonary hypertensive rats. Faber JE; Szymeczek CL; Salvi SS; Zhang H Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2272-81. PubMed ID: 16798826 [TBL] [Abstract][Full Text] [Related]